Literature DB >> 23618519

Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.

Haruhisa Matsuguma1, Izumi Oki, Rie Nakahara, Haruko Suzuki, Takashi Kasai, Yukari Kamiyama, Seiji Igarashi, Kiyoshi Mori, Shunsuke Endo, Kohei Yokoi.   

Abstract

BACKGROUND: A greater proportion of ground-glass opacity (GGO) is well known to be strongly associated with less invasive lung adenocarcinoma. Recently, the solid area diameter has also been reported to be a simple and better marker for the same purpose compared with the whole nodule diameter.
METHODS: From 1997 to 2009, 383 patients with clinical T1-2N0M0 non-small cell lung cancer (NSCLC) with a solid area of 3 cm or less underwent surgical resection, and their preoperative high-resolution computed tomographic images were preserved in Digital Imaging and Communications in Medicine format. Less invasive lung cancer was defined as having no vascular, lymphatic, or pleural invasion or lymph node metastasis. We compared the solid area and whole nodule diameters and proportion of GGO, with the objective of predicting less invasive lung cancer.
RESULTS: Among the 383 patients, 187 were men, 335 had adenocarcinoma histologic type, 242 had less invasive lung cancer, and 43 experienced recurrence. Receiver operating characteristic (ROC) analysis to predict less invasive lung cancer showed that the area under the curve of proportion of GGO was the highest (0.848; 95% confidence interval [CI], 0.810-0.886), followed by the solid area diameter (0.785; 95% CI, 0.740-0.829), and then whole nodule diameter (0.621; 95% CI, 0.565-0.677). Multiple logistic regression analyses revealed that proportion of GGO was the only significant predictor of less invasive lung cancer. The proportion of GGO was also found to be a significant prognostic factor of disease-free survival (DFS) along with solid area diameter by multivariate analysis. Regardless of the solid area diameter, no patient with a greater proportion of GGO (> 50%) experienced recurrence.
CONCLUSIONS: Proportion of GGO remains important for predicting less invasive lung cancer.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23618519     DOI: 10.1016/j.athoracsur.2013.02.022

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  25 in total

1.  The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

Authors:  Morgan L Cox; Chi-Fu Jeffrey Yang; Paul J Speicher; Kevin L Anderson; Zachary W Fitch; Lin Gu; Robert Patrick Davis; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; David H Harpole; Mark F Berry
Journal:  J Thorac Oncol       Date:  2017-01-08       Impact factor: 15.609

2.  Predicting adenocarcinoma recurrence using computational texture models of nodule components in lung CT.

Authors:  Adrien Depeursinge; Masahiro Yanagawa; Ann N Leung; Daniel L Rubin
Journal:  Med Phys       Date:  2015-04       Impact factor: 4.071

3.  Is volumetric 3-dimensional computed tomography useful to predict histological tumour invasiveness? Analysis of 211 lesions of cT1N0M0 lung adenocarcinoma.

Authors:  Kei Shikuma; Toshi Menju; Fengshi Chen; Takeshi Kubo; Shigeo Muro; Shinji Sumiyoshi; Keiji Ohata; Terumasa Sowa; Takao Nakanishi; Hiroyuki Cho; Shinya Neri; Akihiro Aoyama; Toshihiko Sato; Makoto Sonobe; Hiroshi Date
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-25

4.  Prognostic significance of clinical/pathological stage IA non-small-cell lung cancer showing partially solid or solid tumours on radiological exam.

Authors:  Hirofumi Uehara; Yosuke Matsuura; Masayuki Nakao; Mingyon Mun; Ken Nakagawa; Yuichi Ishikawa; Sakae Okumura
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-02-16       Impact factor: 1.520

5.  How to manage patients with subcentimeter non-small cell lung cancer?

Authors:  Tomoyoshi Takenaka
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 6.  Controversies on lung cancers manifesting as part-solid nodules.

Authors:  Rowena Yip; Kunwei Li; Li Liu; Dongming Xu; Kathleen Tam; David F Yankelevitz; Emanuela Taioli; Betsy Becker; Claudia I Henschke
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

7.  Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma.

Authors:  Yingying Miao; Jianya Zhang; Jiawei Zou; Qingqing Zhu; Tangfeng Lv; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2017-02

8.  Pulmonary adenocarcinomas appearing as part-solid ground-glass nodules: is measuring solid component size a better prognostic indicator?

Authors:  Eui Jin Hwang; Chang Min Park; Youngjin Ryu; Sang Min Lee; Young Tae Kim; Young Whan Kim; Jin Mo Goo
Journal:  Eur Radiol       Date:  2014-10-02       Impact factor: 5.315

9.  Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease.

Authors:  Alexander Goehler; Pamela M McMahon; Heidi S Lumish; Carol C Wu; Vidit Munshi; Michael Gilmore; Jonathan H Chung; Brian B Ghoshhajra; Daniel Mark; Quynh A Truong; G Scott Gazelle; Udo Hoffmann
Journal:  Circulation       Date:  2014-07-11       Impact factor: 29.690

10.  Surgical treatment of synchronous multiple primary lung cancers: a retrospective analysis of 122 patients.

Authors:  Ming Liu; Wenxin He; Jie Yang; Gening Jiang
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.